Osteocyte Wnt/β-catenin signaling is required for normal bone homeostasis

Molecular and Cellular Biology

Volumn 30, Issue 12, 2010, Pages 3071-3085

  Kramer, Ina ^a   Halleux, Christine ^a   Keller, Hansjoerg ^a   Pegurri, Marco ^a   Gooi, Jonathan H ^a   Weber, Patricia Brander ^a   Feng, Jian Q ^b   Bonewald, Lynda F ^c   Kneissel, Michaela ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b BAYLOR COLLEGE OF DENTISTRY   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE; BONE GROWTH; BONE MASS; BONE MATURATION; CANCELLOUS BONE; CELL ACTIVITY; CELL COUNT; CELL DENSITY; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL FUNCTION; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICAL BONE; DOWN REGULATION; FEMALE; GENE EXPRESSION; GROWTH RETARDATION; HOMEOSTASIS; LETHALITY; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; OSTEOCLAST; OSTEOCYTE; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THICKNESS;

ANIMALS; ANIMALS, NEWBORN; BETA CATENIN; BONE AND BONES; BONE RESORPTION; CELL COUNT; EMBRYO LOSS; FEMUR; GENE DELETION; HOMEOSTASIS; MICE; MICE, KNOCKOUT; ORGAN SPECIFICITY; OSTEOCLASTS; OSTEOCYTES; SIGNAL TRANSDUCTION; TIME FACTORS; WNT PROTEINS;

MUS;

EID: 77953407742     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01428-09     Document Type: Article

References (73)

1. Aguirre, J. I., L. I. Plotkin, S. A. Stewart, R. S. Weinstein, A. M. Parfitt, S. C. Manolagas, and T. Bellido. 2006. Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss. J. Bone Miner. Res. 21:605-615.
2. Almeida, M., L. Han, M. Martin-Millan, C. A. O'Brien, and S. C. Manolagas. 2007. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. J. Biol. Chem. 282:27298-27305.
3. Armstrong, V. J., M. Muzylak, A. Sunters, G. Zaman, L. K. Saxon, J. S. Price, and L. E. Lanyon. 2007. Wnt/beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha. J. Biol. Chem. 282:20715-20727.
4. Babij, P., W. Zhao, C. Small, Y. Kharode, P. J. Yaworsky, M. L. Bouxsein, P. S. Reddy, P. V. Bodine, J. A. Robinson, B. Bhat, J. Marzolf, R. A. Moran, and F. Bex. 2003. High bone mass in mice expressing a mutant LRP5 gene. J. Bone Miner. Res. 18:960-974.
5. Bennett, C. N., H. Ouyang, Y. L. Ma, Q. Zeng, I. Gerin, K. M. Sousa, T. F. Lane, V. Krishnan, K. D. Hankenson, and O. A. MacDougald. 2007. Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation. J. Bone Miner. Res. 22:1924-1932.
6. Benson, M. D., J. E. Aubin, G. Xiao, P. E. Thomas, and R. T. Franceschi. 1999. Cloning of a 2.5 kb murine bone sialoprotein promoter fragment and functional analysis of putative Osf2 binding sites. J. Bone Miner. Res. 14:396-405.
7. Bodine, P. V., W. Zhao, Y. P. Kharode, F. J. Bex, A. J. Lambert, M. B. Goad, T. Gaur, G. S. Stein, J. B. Lian, and B. S. Komm. 2004. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol. Endocrinol. 18:1222-1237.
8. Bonewald, L. F. 2005. Generation and function of osteocyte dendritic processes. J. Musculoskelet. Neuronal Interact. 5:321-324.
9. Bonewald, L. F. 2006. Mechanosensation and transduction in osteocytes. Bonekey Osteovision 3:7-15.
10. Bonewald, L. F. 2007. Osteocytes as dynamic multifunctional cells. Ann. N. Y. Acad. Sci. 1116:281-290.
11. Bonewald, L. F., and M. L. Johnson. 2008. Osteocytes, mechanosensing and Wnt signaling. Bone 42:606-615.
12. Boyce, B. F., and L. Xing. 2008. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch. Biochem. Biophys. 473:139-146.
13. Brault, V., R. Moore, S. Kutsch, M. Ishibashi, D. H. Rowitch, A. P. McMahon, L. Sommer, O. Boussadia, and R. Kemler. 2001. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 128:1253-1264. (Pubitemid 32409648)
14. Breuil, V., H. Schmid-Antomarchi, A. Schmid-Alliana, R. Rezzonico, L. Euller-Ziegler, and B. Rossi. 2003. The receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) is a new chemotactic factor for human monocytes. FASEB J. 17:1751-1753.
15. Bucay, N., I. Sarosi, C. R. Dunstan, S. Morony, J. Tarpley, C. Capparelli, S. Scully, H. L. Tan, W. Xu, D. L. Lacey, W. J. Boyle, and W. S. Simonet. 1998. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12:1260-1268. (Pubitemid 28213402)
16. Cardoso, L., B. C. Herman, O. Verborgt, D. Laudier, R. J. Majeska, and M. B. Schaffler. 2009. Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue. J. Bone Miner. Res. 24:597-605.
17. Caverzasio, J. 2009. Non-canonical Wnt signaling: what is its role in bone? Bonekey 6:107-115.
18. Day, T. F., X. Guo, L. Garrett-Beal, and Y. Yang. 2005. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 8:739-750.
19. Glass, D. A., II, P. Bialek, J. D. Ahn, M. Starbuck, M. S. Patel, H. Clevers, M. M. Taketo, F. Long, A. P. McMahon, R. A. Lang, and G. Karsenty. 2005. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8:751-764.
20. Gu, G., M. Mulari, Z. Peng, T. A. Hentunen, and H. K. Vaananen. 2005. Death of osteocytes turns off the inhibition of osteoclasts and triggers local bone resorption. Biochem. Biophys. Res. Commun. 335:1095-1101.
21. Gu, G., M. Nars, T. A. Hentunen, K. Metsikko, and H. K. Vaananen. 2006. Isolated primary osteocytes express functional gap junctions in vitro. Cell Tissue Res. 323:263-271.
22. Hedgecock, N. L., T. Hadi, A. A. Chen, S. B. Curtiss, R. B. Martin, and S. J. Hazelwood. 2007. Quantitative regional associations between remodeling, modeling, and osteocyte apoptosis and density in rabbit tibial midshafts. Bone 40:627-637.
23. Heino, T. J., T. A. Hentunen, and H. K. Vaananen. 2004. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts. Exp. Cell Res. 294:458-468.
24. Henriksen, K., A. V. Neutzsky-Wulff, L. F. Bonewald, and M. A. Karsdal. 2009. Local communication on and within bone controls bone remodeling. Bone 44:1026-1033.
25. Hill, T. P., D. Spater, M. M. Taketo, W. Birchmeier, and C. Hartmann. 2005. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev. Cell 8:727-738.
26. Holmen, S. L., C. R. Zylstra, A. Mukherjee, R. E. Sigler, M. C. Faugere, M. L. Bouxsein, L. Deng, T. L. Clemens, and B. O. Williams. 2005. Essential role of beta-catenin in postnatal bone acquisition. J. Biol. Chem. 280:21162-21168.
27. Hu, H., M. J. Hilton, X. Tu, K. Yu, D. M. Ornitz, and F. Long. 2005. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132:49-60.
28. Inouye, M. 1976. Differential staining of cartilage and bone in fetal mouse skeleton by alcian blue and alizarin red-S. Congen. Anom. 16:171-173.
29. Jho, E. H., T. Zhang, C. Domon, C. K. Joo, J. N. Freund, and F. Costantini. 2002. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 22:1172-1183.
30. Kamioka, H., T. Honjo, and T. Takano-Yamamoto. 2001. A three-dimensional distribution of osteocyte processes revealed by the combination of confocal laser scanning microscopy and differential interference contrast microscopy. Bone 28:145-149.
31. Kato, M., M. S. Patel, R. Levasseur, I. Lobov, B. H. Chang, D. A. Glass II, C. Hartmann, L. Li, T. H. Hwang, C. F. Brayton, R. A. Lang, G. Karsenty, and L. Chan. 2002. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell Biol. 157:303-314.
32. Keller, H., and M. Kneissel. 2005. SOST is a target gene for PTH in bone. Bone 37:148-158.
33. Kneissel, M., A. Boyde, and J. A. Gasser. 2001. Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34). Bone 28:237-250.
34. Kurata, K., T. J. Heino, H. Higaki, and H. K. Vaananen. 2006. Bone marrow cell differentiation induced by mechanically damaged osteocytes in 3D gel-embedded culture. J. Bone Miner. Res. 21:616-625.
35. Lam, J., C. A. Nelson, F. P. Ross, S. L. Teitelbaum, and D. H. Fremont. 2001. Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity. J. Clin. Invest. 108:971-979.
36. Leung, J. Y., F. T. Kolligs, R. Wu, Y. Zhai, R. Kuick, S. Hanash, K. R. Cho, and E. R. Fearon. 2002. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. J. Biol. Chem. 277:21657-21665.
37. Li, X., M. S. Ominsky, Q. T. Niu, N. Sun, B. Daugherty, D. D'Agostin, C. Kurahara, Y. Gao, J. Cao, J. Gong, F. Asuncion, M. Barrero, K. Warmington, D. Dwyer, M. Stolina, S. Morony, I. Sarosi, P. J. Kostenuik, D. L. Lacey, W. S. Simonet, H. Z. Ke, and C. Paszty. 2008. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J. Bone Miner. Res. 23:860-869.
38. Liang, M., G. Russell, and P. A. Hulley. 2008. Bim, Bak, and Bax regulate osteoblast survival. J. Bone Miner. Res. 23:610-620.
39. Lin, C., X. Jiang, Z. Dai, X. Guo, T. Weng, J. Wang, Y. Li, G. Feng, X. Gao, and L. He. 2009. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J. Bone Miner. Res. 24:1651-1661.
40. Liu, F., S. Kohlmeier, and C. Y. Wang. 2008. Wnt signaling and skeletal development. Cell Signal. 20:999-1009.
41. Liu, X. H., A. Kirschenbaum, S. Yao, and A. C. Levine. 2007. Androgens promote preosteoblast differentiation via activation of the canonical Wnt signaling pathway. Ann. N. Y. Acad. Sci. 1116:423-431.
42. Lu, Y., Y. Xie, S. Zhang, V. Dusevich, L. F. Bonewald, and J. Q. Feng. 2007. DMP1-targeted Cre expression in odontoblasts and osteocytes. J. Dent. Res. 86:320-325.
43. Lustig, B., B. Jerchow, M. Sachs, S. Weiler, T. Pietsch, U. Karsten, M. van de Wetering, H. Clevers, P. M. Schlag, W. Birchmeier, and J. Behrens. 2002. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol. Cell. Biol. 22:1184-1193.
44. Manolagas, S. C., and M. Almeida. 2007. Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Mol. Endocrinol. 21:2605-2614.
45. Martin, R. B. 2000. Does osteocyte formation cause the nonlinear refilling of osteons? Bone 26:71-78.
46. Martin, T., J. H. Gooi, and N. A. Sims. 2009. Molecular mechanisms in coupling of bone formation to resorption. Crit. Rev. Eukaryot. Gene Expr. 19:73-88.
47. Mbalaviele, G., C. S. Shin, and R. Civitelli. 2006. Cell-cell adhesion and signaling through cadherins: connecting bone cells in their microenvironment. J. Bone Miner. Res. 21:1821-1827.
48. Mizuno, A., N. Amizuka, K. Irie, A. Murakami, N. Fujise, T. Kanno, Y. Sato, N. Nakagawa, H. Yasuda, S. Mochizuki, T. Gomibuchi, K. Yano, N. Shima, N. Washida, E. Tsuda, T. Morinaga, K. Higashio, and H. Ozawa. 1998. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/ osteoprotegerin. Biochem. Biophys. Res. Commun. 247:610-615.
49. Noble, B. S., N. Peet, H. Y. Stevens, A. Brabbs, J. R. Mosley, G. C. Reilly, J. Reeve, T. M. Skerry, and L. E. Lanyon. 2003. Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone. Am. J. Physiol. Cell Physiol. 284:C934-C943.
50. Noh, T., Y. Gabet, J. Cogan, Y. Shi, A. Tank, T. Sasaki, B. Criswell, A. Dixon, C. Lee, J. Tam, T. Kohler, E. Segev, L. Kockeritz, J. Woodgett, R. Muller, Y. Chai, E. Smith, I. Bab, and B. Frenkel. 2009. Lef1 haploinsufficient mice display a low turnover and low bone mass phenotype in a gender- and age-specific manner. PLoS One 4:e5438.
51. Onyia, J. E., R. R. Miles, X. Yang, D. L. Halladay, J. Hale, A. Glasebrook, D. McClure, G. Seno, L. Churgay, S. Chandrasekhar, and T. J. Martin. 2000. In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene. J. Bone Miner. Res. 15:863-871.
52. Paic, F., J. C. Igwe, R. Nori, M. S. Kronenberg, T. Franceschetti, P. Harrington, L. Kuo, D. G. Shin, D. W. Rowe, S. E. Harris, and I. Kalajzic. 2009. Identification of differentially expressed genes between osteoblasts and osteocytes. Bone 45:682-692.
53. Parfitt, A. M., M. K. Drezner, F. H. Glorieux, J. A. Kanis, H. Malluche, P. J. Meunier, S. M. Ott, and R. R. Recker. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2:595-610.
54. Pederson, L., M. Ruan, J. J. Westendorf, S. Khosla, and M. J. Oursler. 2008. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc. Natl. Acad. Sci. U. S. A. 105:20764-20769.
55. Piters, E., E. Boudin, and W. Van Hul. 2008. Wnt signaling: a win for bone. Arch. Biochem. Biophys. 473:112-116.
56. Robinson, J. A., M. Chatterjee-Kishore, P. J. Yaworsky, D. M. Cullen, W. Zhao, C. Li, Y. Kharode, L. Sauter, P. Babij, E. L. Brown, A. A. Hill, M. P. Akhter, M. L. Johnson, R. R. Recker, B. S. Komm, and F. J. Bex. 2006. Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone. J. Biol. Chem. 281:31720-31728.
57. Robling, A. G., P. J. Niziolek, L. A. Baldridge, K. W. Condon, M. R. Allen, I. Alam, S. M. Mantila, J. Gluhak-Heinrich, T. M. Bellido, S. E. Harris, and C. H. Turner. 2008. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J. Biol. Chem. 283:5866-5875.
58. Sawakami, K., A. G. Robling, M. Ai, N. D. Pitner, D. Liu, S. J. Warden, J. Li, P. Maye, D. W. Rowe, R. L. Duncan, M. L. Warman, and C. H. Turner. 2006. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J. Biol. Chem. 281:23698-23711.
59. Shah, S., A. Hecht, R. Pestell, and S. W. Byers. 2003. Trans-repression of beta-catenin activity by nuclear receptors. J. Biol. Chem. 278:48137-48145.
60. Tami, A. E., M. B. Schaffler, and M. L. Knothe Tate. 2003. Probing the tissue to subcellular level structure underlying bone's molecular sieving function. Biorheology 40:577-590.
61. Tatsumi, S., K. Ishii, N. Amizuka, M. Li, T. Kobayashi, K. Kohno, M. Ito, S. Takeshita, and K. Ikeda. 2007. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab. 5:464-475.
62. Toyosawa, S., S. Shintani, T. Fujiwara, T. Ooshima, A. Sato, N. Ijuhin, and T. Komori. 2001. Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts. J. Bone Miner. Res. 16:2017-2026.
63. Vaananen, H. K., and T. Laitala-Leinonen. 2008. Osteoclast lineage and function. Arch. Biochem. Biophys. 473:132-138.
64. van Bezooijen, R. L., B. A. Roelen, A. Visser, L. van der Wee-Pals, E. de Wilt, M. Karperien, H. Hamersma, S. E. Papapoulos, P. ten Dijke, and C. W. Lowik. 2004. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J. Exp. Med. 199:805-814.
65. Verborgt, O., N. A. Tatton, R. J. Majeska, and M. B. Schaffler. 2002. Spatial distribution of Bax and Bcl-2 in osteocytes after bone fatigue: complementary roles in bone remodeling regulation? J. Bone Miner. Res. 17:907-914.
66. Wang, L., C. Ciani, S. B. Doty, and S. P. Fritton. 2004. Delineating bone's interstitial fluid pathway in vivo. Bone 34:499-509.
67. Weinbaum, S., S. C. Cowin, and Y. Zeng. 1994. A model for the excitation of osteocytes by mechanical loading-induced bone fluid shear stresses. J. Biomech. 27:339-360.
68. Winkler, D. G., M. K. Sutherland, J. C. Geoghegan, C. Yu, T. Hayes, J. E. Skonier, D. Shpektor, M. Jonas, B. R. Kovacevich, K. Staehling-Hampton, M. Appleby, M. E. Brunkow, and J. A. Latham. 2003. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 22:6267-6276.
69. Yan, Y., D. Tang, M. Chen, J. Huang, R. Xie, J. H. Jonason, X. Tan, W. Hou, D. Reynolds, W. Hsu, S. E. Harris, J. E. Puzas, H. Awad, R. J. O'Keefe, B. F. Boyce, and D. Chen. 2009. Axin2 controls bone remodeling through the β-catenin-BMP signaling pathway in adult mice. J. Cell Sci. 122:3566-3578.
70. Yochum, G. S., S. McWeeney, V. Rajaraman, R. Cleland, S. Peters, and R. H. Goodman. 2007. Serial analysis of chromatin occupancy identifies beta-catenin target genes in colorectal carcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 104:3324-3329.
71. You, L., S. Temiyasathit, P. Lee, C. H. Kim, P. Tummala, W. Yao, W. Kingery, A. M. Malone, R. Y. Kwon, and C. R. Jacobs. 2008. Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading. Bone 42:172-179.
72. Zaman, G., H. L. Jessop, M. Muzylak, R. L. De Souza, A. A. Pitsillides, J. S. Price, and L. L. Lanyon. 2006. Osteocytes use estrogen receptor alpha to respond to strain but their ERalpha content is regulated by estrogen. J. Bone Miner. Res. 21:1297-1306.
73. Zhao, S., Y. K. Zhang, S. Harris, S. S. Ahuja, and L. F. Bonewald. 2002. MLO-Y4 osteocyte-like cells support osteoclast formation and activation. J. Bone Miner. Res. 17:2068-2079.